Y Atef1, T W Koedam1, S E van Oostendorp1, H J Bonjer1, A R Wijsmuller2, J B Tuynman1. 1. Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands. 2. Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands. a.r.wijsmuller@umcg.nl.
Abstract
BACKGROUND: Synchronous lateral pelvic lymph node (LPLN) involvement occurs in a significant number of patients with rectal cancer. The aim of this study is to determine the rate of LPLN metastases in rectal cancer patients with LPLN suspicious for metastases (LPLNSM) on pretreatment imaging, treated with neoadjuvant chemoradiotherapy (nCRT). Additionally, the influence of LPLN responsiveness to nCRT as determined by post-nCRT restaging scan was investigated. METHODS: A systematic review was conducted to identify studies on patients with author-defined LPLNSM that reported the pathological outcomes after total mesorectal excision (TME) with lateral pelvic lymph node dissection (LPLD). MEDLINE, EMBASE, Web of Science and the Cochrane Library were searched. The primary outcome was the percentage of pathologically confirmed LPLN metastases. RESULTS: A total of 462 patients from eleven studies were identified. The number of pathologically confirmed LPLN metastases in 361 patients that underwent uni- or bilateral LPLD ranged from 21.9 to 61.1%. The LPLD resulted in pathologically confirmed metastases in a range from 0 to 20.4% of patients with responsive LPLNSM and in a range from 25.0 to 83.3% of patients with persistent nodes. However, radiologic cutoff criteria for the evaluation of LPLN differed between studies. CONCLUSIONS: In a large number of patients with LPLNSM on initial imaging, metastatic LPLN are present after nCRT and surgical treatment. Even in LPLN that are considered responsive on restaging, significant rates of pathologically confirmed metastases are reported.
BACKGROUND: Synchronous lateral pelvic lymph node (LPLN) involvement occurs in a significant number of patients with rectal cancer. The aim of this study is to determine the rate of LPLNmetastases in rectal cancerpatients with LPLN suspicious for metastases (LPLNSM) on pretreatment imaging, treated with neoadjuvant chemoradiotherapy (nCRT). Additionally, the influence of LPLN responsiveness to nCRT as determined by post-nCRT restaging scan was investigated. METHODS: A systematic review was conducted to identify studies on patients with author-defined LPLNSM that reported the pathological outcomes after total mesorectal excision (TME) with lateral pelvic lymph node dissection (LPLD). MEDLINE, EMBASE, Web of Science and the Cochrane Library were searched. The primary outcome was the percentage of pathologically confirmed LPLNmetastases. RESULTS: A total of 462 patients from eleven studies were identified. The number of pathologically confirmed LPLNmetastases in 361 patients that underwent uni- or bilateral LPLD ranged from 21.9 to 61.1%. The LPLD resulted in pathologically confirmed metastases in a range from 0 to 20.4% of patients with responsive LPLNSM and in a range from 25.0 to 83.3% of patients with persistent nodes. However, radiologic cutoff criteria for the evaluation of LPLN differed between studies. CONCLUSIONS: In a large number of patients with LPLNSM on initial imaging, metastatic LPLN are present after nCRT and surgical treatment. Even in LPLN that are considered responsive on restaging, significant rates of pathologically confirmed metastases are reported.
Authors: Howard Balshem; Mark Helfand; Holger J Schünemann; Andrew D Oxman; Regina Kunz; Jan Brozek; Gunn E Vist; Yngve Falck-Ytter; Joerg Meerpohl; Susan Norris; Gordon H Guyatt Journal: J Clin Epidemiol Date: 2011-01-05 Impact factor: 6.437
Authors: O C Shihab; F Taylor; N Bees; H Blake; N Jeyadevan; R Bleehen; L Blomqvist; M Creagh; C George; A Guthrie; H Massouh; D Peppercorn; B J Moran; R J Heald; P Quirke; P Tekkis; G Brown Journal: Br J Surg Date: 2011-09-16 Impact factor: 6.939
Authors: Ui Sup Shin; Y Nancy You; Alexander T Nguyen; Brian K Bednarski; Craig Messick; Dipen M Maru; Erin M Dean; Sa T Nguyen; Chung-Yuan Hu; George J Chang Journal: Ann Surg Oncol Date: 2016-02-08 Impact factor: 5.344
Authors: Sanne M E Engelen; Regina G H Beets-Tan; Max J Lahaye; Guido Lammering; Rob L H Jansen; Ronald M van Dam; Joop Konsten; Jeroen W A Leijtens; Cornelis J H van de Velde; Geerard L Beets Journal: Dis Colon Rectum Date: 2010-07 Impact factor: 4.585
Authors: Al B Benson; Tanios Bekaii-Saab; Emily Chan; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Paul F Engstrom; Peter C Enzinger; Marwan G Fakih; Charles S Fuchs; Jean L Grem; Steven Hunt; Lucille A Leong; Edward Lin; Michael G Martin; Kilian Salerno May; Mary F Mulcahy; Kate Murphy; Eric Rohren; David P Ryan; Leonard Saltz; Sunil Sharma; David Shibata; John M Skibber; William Small; Constantinos T Sofocleous; Alan P Venook; Christopher G Willett; Deborah A Freedman-Cass; Kristina M Gregory Journal: J Natl Compr Canc Netw Date: 2012-12-01 Impact factor: 11.908
Authors: Min Ju Kim; Bo Yun Hur; Eun Sun Lee; Boram Park; Jungnam Joo; Min Jung Kim; Sung Chan Park; Ji Yeon Baek; Hee Jin Chang; Dae Yong Kim; Jae Hwan Oh Journal: PLoS One Date: 2018-04-12 Impact factor: 3.240
Authors: Michael K Turgeon; Adriana C Gamboa; Jessica M Keilson; Jeffrey Maniko; Lillias Maguire; Katherine Hrebinko; Jennifer Holder-Murray; Jason T Wiseman; Sherif Abdel-Misih; Saif Hamdan; Alexander T Hawkins; Philip Bauer; Matthew Silviera; Shishir K Maithel; Glen C Balch Journal: J Surg Oncol Date: 2021-07-16 Impact factor: 2.885
Authors: Gabriele Anania; Richard Justin Davies; Alberto Arezzo; Francesco Bagolini; Vito D'Andrea; Luigina Graziosi; Salomone Di Saverio; Georgi Popivanov; Isaac Cheruiyot; Roberto Cirocchi; Annibale Donini Journal: Int J Colorectal Dis Date: 2021-06-14 Impact factor: 2.571